Blood Glucose Monitoring Systems Market Report 2026

Blood Glucose Monitoring Systems Market Overview

• Blood Glucose Monitoring Systems market size has reached to $17.66 billion in 2025 • Expected to grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Impact Of The Rising Diabetic Population On The Blood Glucose Monitoring Systems Market • Market Trend: Innovative Solutions Enhanced Glucose Monitoring Systems Market Growth • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Blood Glucose Monitoring Systems Market?

A blood glucose monitoring system is a medical device used to measure and display the concentration of glucose in the blood. It typically consists of a small, portable meter and a test strip where a drop of blood from a fingertip is applied. This system is crucial for managing diabetes by helping individuals monitor and control their blood sugar levels. The main types of blood glucose monitoring systems are non-invasive and invasive. Non-invasive blood glucose monitoring systems refer to devices that measure blood glucose levels without needing to draw blood. These devices include continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. They are distributed through institutional and retail sales channels, catering to applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.

What Is The Blood Glucose Monitoring Systems Market Growth Forecast?

The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for continuous glucose monitoring and flash monitoring systems, increasing adoption of wearable and implantable monitoring devices, higher uptake of remote and connected diabetes management solutions, growing penetration of non-invasive glucose sensing technologies, expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends in the forecast period include increasing adoption of continuous and real-time blood glucose monitoring solutions, rising shift toward minimally invasive and non-invasive glucose monitoring technologies, growing use of portable, home-based, and self-monitoring glucose devices, expansion of blood glucose monitoring in preventive and chronic disease management, focus on enhancing accuracy, convenience, and patient control in diabetes care.

Global Blood Glucose Monitoring Systems Market Segmentation

1) By Type: Non-Invasive, Invasive 2) By Device Type: Continuous Glucose Monitoring Systems, Self-Monitoring Blood Glucose Systems 3) By Testing Site: Fingertip Testing, Alternate Site Testing 4) By Distribution Channel: Institutional Sales, Retail Sales 5) By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes Subsegments: 1) By Non-Invasive: Optical Sensors, Ultrasound-Based Sensors, Bioimpedance-Based Sensors, Electromagnetic Sensors, Tear Or Saliva-Based Sensors 2) By Invasive: Continuous Glucose Monitoring (CGM) Systems, Self-Monitoring Blood Glucose (SMBG) Systems, Implantable Glucose Monitoring Devices, Flash Glucose Monitoring Systems

What Is The Driver Of The Blood Glucose Monitoring Systems Market?

The rising prevalence of the diabetic population is expected to propel the growth of the blood glucose monitoring systems market going forward. The prevalence of the diabetic population is rising due to factors such as sedentary lifestyles, unhealthy diets, aging populations, and genetic predisposition. Blood glucose monitoring systems are used for monitoring and managing blood sugar levels, aiding disease control, and preventing complications. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050 and with more than 4 in 5 adults with diabetes residing in low and middle income countries. Factors such as being born overseas, living in disadvantaged areas, and having a disability are associated with higher diabetes rates. Therefore, the rising prevalence of the diabetic population will drive the blood glucose monitoring systems industry.

Key Players In The Global Blood Glucose Monitoring Systems Market

Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.

Global Blood Glucose Monitoring Systems Market Trends and Insights

Major companies operating in the glucose monitoring systems market are focused on developing innovative glucose monitoring systems such as advanced hybrid closed-loop systems and smartphone apps for real-time data access and management. Advanced hybrid closed-loop systems refer to glucose monitoring systems that automate insulin delivery based on real-time glucose levels, improving blood sugar control in individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based continuous glucose monitoring systems manufacturing company, launched Dexcom ONE+ in several European countries. Dexcom ONE+ incorporates the company's best-in-class sensor technology and features designed to provide an easy-to-use, highly effective continuous glucose monitoring (CGM) experience for people with type 1 or type 2 diabetes who use insulin. The system consists of a water-resistant sensor, a transmitter that sends CGM readings, and a Dexcom One smartphone-compatible app. Dexcom ONE+ allows for real-time monitoring of blood glucose by both the user and up to ten additional people, enabling shared monitoring.

What Are Latest Mergers And Acquisitions In The Blood Glucose Monitoring Systems Market?

In September 2023, Abbott Laboratories, a US-based medical device manufacturing company, acquired Bigfoot Biomedical Inc. for an undisclosed amount. This acquisition broadens and strengthens Abbott’s product offerings for glucose monitoring and insulin management for diabetic patients. Bigfoot Biomedical Inc. is a US-based medical device manufacturing company that develops diabetes management technology.

Regional Outlook

North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Blood Glucose Monitoring Systems Market?

The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.